Skip to main content
SpringerLink
Log in

The boundaries of schizophrenia: Overlap with bipolar disorders

  • Published:
Current Psychosis and Therapeutics Reports

Abstract

The extent to which schizophrenia and bipolar disorder converge or diverge across a range of domains is a fundamental construct in psychiatric nosology and neuroscience. Both conditions share overlapping symptomatology and the Kraepelinian dichotomy that course of illness helps define and separate each condition longitudinally is, at best, contentious. Schizophrenia and bipolar disorders both show high rates of heritability, with recent whole genome linkage studies providing some evidence for shared genetic liability. On the other hand, the available evidence suggests a greater influence of nongenetic factors in schizophrenia than in bipolar disorders. There are also subtle differences in structural brain abnormalities and in cellular architecture between these conditions. In the area where perhaps heretofore there was the greatest divergence, emerging information suggests an overlap in therapeutic efficacy between medications used for the treatment of schizophrenia and those agents used for treating mood disorders. Pertinent aspects of etiopathogenesis as well as recent publications that address overlapping domains between schizophrenia and mood disorders are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Moller HJ:Bipolar disorder and schizophrenia: distinct illnesses or a continuum? J Clin Psychiatry 2003,64(Suppl 6):23–27.

    PubMed  Google Scholar 

  2. Adler CM, Strakowski SM:Boundaries of schizophrenia.Psychiatr Clin North Am 2003,26:1–23.

    Article  PubMed  Google Scholar 

  3. Casey DE, Daniel DG, Wassef AA,et al.:Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.Neuropsychopharmacology 2003,28:182–192.

    Article  PubMed  CAS  Google Scholar 

  4. Buckley P:2001 Broader therapeutic profile of atypical antipsychotics.Biol Psychiatry 2001,50:912–924.

    Article  PubMed  CAS  Google Scholar 

  5. Ketter TA, Wang PW, Becker OV,et al.:Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? J Psychiatr Res 2004,38:47–61.

    Article  PubMed  Google Scholar 

  6. Boteva K, Lieberman J:Reconsidering the classification of schizophrenia and manic depressive illness-a critical analysis and new conceptual model.World J Biol Psychiatry 2003,4:81–92.

    Article  PubMed  Google Scholar 

  7. Ketter TA, Wang PW, Becker OV,et al.:Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? J Psychiatry Res 2004,38:47–61.

    Article  Google Scholar 

  8. Arduini L, Kalyvoka A, Stratta P,et al.:Insight and neuropsychological function in patients with schizophrenia and bipolar disorder with psychotic features.Can J Psychiatry 2003,48:338–341.

    PubMed  Google Scholar 

  9. Quraishi S, Frangou S:Neuropsychology of bipolar disorder: a review.J Affect Disord 2002,72:209–226.

    Article  PubMed  Google Scholar 

  10. Birchwood M, Iqbal Z, Chadwick P, Trower P:Cognitive approach to depression and suicidal thinking in psychosis: ontogeny of post psychotic depression.Br J Psychiatry 2001,177:516–521.

    Article  Google Scholar 

  11. Marneros A:Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment.Curr Psychiatry Rep 2003,5:202–205.

    Article  PubMed  Google Scholar 

  12. Angst J:Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia.Schizophr Res 2002,57:5–13.

    Article  PubMed  Google Scholar 

  13. Tohen M, Zarate CA Jr, Hennen J,et al.:The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.Am J Psychiatry 2003,160:2099–2107.

    Article  PubMed  Google Scholar 

  14. Modestin J, Huber A, Satirli E,et al.:Long-term course of schizophrenic illness: Bleuler’s study reconsidered.Am J Psychiatry 2003,160:2202–2208.

    Article  PubMed  Google Scholar 

  15. Robinson DG, Woerner MG, MacMeniman M,et al.:Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder.Am J Psychiatry 2004,161:473–479.

    Article  PubMed  Google Scholar 

  16. Baethge C, Salvatore P, Baldessarini RJ: “On cyclic insanity” by Karl Ludwig Kahlbaum, MD: a translation and commentary.Harv Rev Psychiatry 2003,11:78–90.

    Article  PubMed  Google Scholar 

  17. Taylor MA, Fink M:Catatonia in psychiatric classification: a home of its own.Am J Psychiatry 2003,160:1233–1241.

    Article  PubMed  Google Scholar 

  18. Havassy BE, Alvidrez J, Owen KK:Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.Am J Psychiatry 2004,161:139–145.

    Article  PubMed  Google Scholar 

  19. Tondo L, Isacsson G, Baldessarini R:Suicidal behaviour in bipolar disorder: risk and prevention.CNS Drugs 2003,17:491–511.

    Article  PubMed  CAS  Google Scholar 

  20. Baldessarini RJ, Tondo L, Hennen J:Lithium treatment and suicide risk in major affective disorders: update and new findings.J Clin Psychiatry 2003,64(Suppl 5):44–52.

    PubMed  CAS  Google Scholar 

  21. Meltzer HY, Alphs L, Green AI,et al.:International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).Arch Gen Psychiatry 2003,60:82–91.

    Article  PubMed  CAS  Google Scholar 

  22. Spivak B, Shabash E, Sheitman B,et al.:The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.J Clin Psychiatry 2003,64:755–760.

    Article  PubMed  CAS  Google Scholar 

  23. Uhl GR, Grow RW:The burden of complex genetics in brain disorders.Arch Gen Psychiatry 2004,61:223–229.

    Article  PubMed  Google Scholar 

  24. Kennedy JL, Farrer LA, Andreasen NC,et al.:The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 2003,302:822–826.

    Article  PubMed  CAS  Google Scholar 

  25. Tsuang MT, Taylor L, Faraone SV:An overview of the genetics of psychotic mood disorders.J Psychiatry Res 2004,38:3–15.

    Article  Google Scholar 

  26. Segurado R, Detera-Wadleigh SD, Levinson DF,et al.:Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder.Am J Hum Genet 2003,73:49–62.

    Article  PubMed  CAS  Google Scholar 

  27. Lewis CM, Levinson DF, Wise LH,et al.:Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia.Am J Hum Genet 2003,73:34–48.

    Article  PubMed  CAS  Google Scholar 

  28. Kathmann N, Hockrein A, Uwer R, Bondy B:Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives.Am J Psychiatry 2003,160:696–702.

    Article  PubMed  Google Scholar 

  29. Zalla T, Joyce C, Szoke A,et al.:Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.Psychiatry Res 2004,121:207–217.

    Article  PubMed  Google Scholar 

  30. Buckley PF, Mahadik S, Evans D, Stirewalt E:Schizophrenia: causes, course, and neurodevelopment.Curr Psychosis Therapeut Rep 2003,1:41–49.

    Article  Google Scholar 

  31. Tsuchiya KJ, Byrne M, Mortensen PB:Risk factors in relation to an emergence of bipolar disorder: a systematic review.Bipolar Disord 2003,5:231–242.

    Article  PubMed  Google Scholar 

  32. Byrne M, Agerbo E, Ewald H,et al.:Parental age and risk of schizophrenia: a case-control study.Arch Gen Psychiatry 2003,60:673–678.

    Article  PubMed  Google Scholar 

  33. Mortensen PB, Pedersen CB, Melbye M,et al.:Individual and familial risk factors for bipolar affective disorders in Denmark.Arch Gen Psychiatry 2003,60:1209–1215.

    Article  PubMed  Google Scholar 

  34. Sallet PC, Elkis H, Alves TM,et al.:Reducing cortical folding in schizophrenia: an MRI morphometric study.Am J Psychiatry 2003,160:1606–1613.

    Article  PubMed  Google Scholar 

  35. Callicott JH, Mattay VS, Verchinski BA,et al.:Complexity of premotor cortical dysfunction in schizophrenia: more than up or down.Am J Psychiatry 2003,160:2209–2215.

    Article  PubMed  Google Scholar 

  36. Lim KF, Rosenbloom MJ, Faustman WO,et al.:Cortical gray matter deficit in patients with bipolar disorder.Schizophr Res 1999,40:219–227.

    Article  PubMed  CAS  Google Scholar 

  37. Lopez-Larson MP, DelBello MP, Zimmerman ME:Regional prefrontal gray and white matter abnormalities in bipolar disorder.Biol Psychiatry 2002,52:93–100.

    Article  PubMed  Google Scholar 

  38. Altshuler L.L., Bartzokis G, Grieder T,et al.:Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity.Arch Gen Psychiatry 1998,55:663–664.

    Article  PubMed  CAS  Google Scholar 

  39. Okugawa G, Sedvall GC, Agartz I:Smaller cerebellar vermis but not hemisphere volumes in patients with chronic schizophrenia.Am J Psychiatry 2003,160:1614–1617.

    Article  PubMed  Google Scholar 

  40. Narr KL, Sharma T, Woods RP,et al.:Increases in regional subarachnoid CSF without apparent cortical gray matter deficits in schizophrenia: modulating effects of sex and age.Am J Psychiatry 2003,160:2169–2180.

    Article  PubMed  Google Scholar 

  41. Nudmamud S, Reynolds LM, Reynolds GP,et al.:N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar: a postmortem study.Biol Psychiatry 2003,53:1138–1141.

    Article  PubMed  CAS  Google Scholar 

  42. Bertolino A, Frye M, Callicott JH:Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.Biol Psychiatry 2003,53:906–913.

    Article  PubMed  Google Scholar 

  43. Deicken RF, Pegues MP, Anzalone S:Lower concentration of hippocampal N-acetylaspartate in familiar bipolar I disorder.Am J Psychiatry 2003,160:873–882.

    Article  PubMed  Google Scholar 

  44. Brown R, Colter N, Corellis JA,et al.:Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area and parahippocampal gyrus compared with affective disorder.Arch Gen Psychiatry 1986,43:36–42.

    PubMed  CAS  Google Scholar 

  45. Highley JR, Walker MA, McDonald B,et al.:Size of hippocampal pyramidal neurons in schizophrenia.Br J Psychiatry 2003,183:414–417.

    Article  PubMed  CAS  Google Scholar 

  46. Chana G, Landau S, Beasley C,et al.:Two-dimensional assessment of cytoarchitecture in the anterior cingulated cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density.Biol Psychiatry 2003,53:1086–1098.

    Article  PubMed  Google Scholar 

  47. Thomas EA, Dean B, Scarr E,et al.:Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.Mol Psychiatry 2003,8:167–175.

    Article  PubMed  CAS  Google Scholar 

  48. Mahadik S, Evans DR:The phospholipid hypothesis of schizophrenia.Psych Clin North Am 2003,26:54–73.

    Article  Google Scholar 

  49. Noaghiul S, Hibbeln JR:Cross-national comparisons of sea-food consumption and rates of bipolar disorders.Am J Psychiatry 2003,160:2222–2227.

    Article  PubMed  Google Scholar 

  50. Koh PO, Undie AS, Kabbani N,et al.:Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients.Proc. Natl Acad Sci U S A 2003,100:313–317.

    Article  PubMed  CAS  Google Scholar 

  51. Lopez-Figueroa AL, Norton CS, Lopez-Figueroa MO,et al.:Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia.Biol Psychiatry 2004,55:225–233.

    Article  PubMed  CAS  Google Scholar 

  52. Yatham LN:Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.Bipolar Disord 2003,2(Suppl 2):7–19.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Medical College of Georgia, 1515 Pope Avenue, 30912, Augusta, GA, USA

    Peter F. Buckley MD

Authors
  1. Peter F. Buckley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda Gowans MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Simon Sebastian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ananda Pathiraja MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Audra Brimeyer BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edna Stirewalt MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buckley, P.F., Gowans, A., Sebastian, C.S. et al. The boundaries of schizophrenia: Overlap with bipolar disorders. Curr psych & therapeutics rep 2, 49–56 (2004). https://doi.org/10.1007/s11922-004-0031-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11922-004-0031-8

Keywords

Search

Navigation